Combined oral contraceptive pill may leads to higher adverse events: nausea compared with contraceptive vaginal ring (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether combined oral contraceptive pill changes adverse effects ‐ Any adverse events compared with levonorgestrel‐releasing intrauterine system (very low certainty).
Combined oral contraceptive pill probably leads to higher adverse events ‐ Any adverse events (treatment‐emergent) compared with placebo (moderate certainty).
Oral contraceptive pill (OCP) may leads to lower adverse events ‐ Minor compared with metformin combined with OCP (low certainty).
The review found no eligible studies for this question.
Oral contraceptive pill (OCP) may leads to lower adverse events ‐ Severe compared with metformin combined with OCP (low certainty).
It is very uncertain whether oral contraceptive pill (OCP) changes adverse events ‐ Severe compared with metformin combined with OCP (very low certainty).
Combined OCP probably leads to higher adverse events compared with placebo or no treatment (moderate certainty).
The review found no eligible studies for this question.
Metformin showed no clear difference in adverse events ‐ Severe compared with metformin combined with oral contraceptive pill (OCP) (low certainty).
Combined low‐dose OCP may leads to higher adverse events for continuous vs standard regimen OCP compared with another combined low‐dose OCP (low certainty).
The review found no eligible studies for this question.
Metformin may leads to higher adverse events ‐ Severe compared with oral contraceptive pill (OCP) (low certainty).
The review found no eligible studies for this question.